Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study

IF 5 2区 医学 Q2 Medicine Translational Oncology Pub Date : 2024-07-08 DOI:10.1016/j.tranon.2024.102050
Shu-Han Xie , Wan-Fei Zhang , Yue Wu , Zi-Lu Tang , Li-Tao Yang , Yun-Jing Xue , Jiang-Bo Lin , Ming-Qiang Kang
{"title":"Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study","authors":"Shu-Han Xie ,&nbsp;Wan-Fei Zhang ,&nbsp;Yue Wu ,&nbsp;Zi-Lu Tang ,&nbsp;Li-Tao Yang ,&nbsp;Yun-Jing Xue ,&nbsp;Jiang-Bo Lin ,&nbsp;Ming-Qiang Kang","doi":"10.1016/j.tranon.2024.102050","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Development and validation of a radiomics model for predicting occult locally advanced esophageal squamous cell carcinoma (LA-ESCC) on computed tomography (CT) radiomic features before implementation of treatment.</p></div><div><h3>Methods</h3><p>The study retrospectively collected 574 patients with esophageal squamous cell carcinoma (ESCC) from two medical centers, which were divided into three cohorts for training, internal and external validation. After delineating volume of interest (VOI), radiomics features were extracted and subjected to feature selection using three robust methods. Subsequently, 10 machine learning models were constructed, among which the optimal model was utilized to establish a radiomics signature. Furthermore, a predictive nomogram incorporating both clinical and radiomics signatures was developed. The performance of these models was evaluated through receiver operating characteristic curves, calibration curves, decision curve analysis as well as measures including accuracy, sensitivity, and specificity.</p></div><div><h3>Results</h3><p>A total of 19 radiomics features were selected. The multilayer perceptron (MLP), which was found to be optimal, achieved an AUC of 0.919, 0.864 and 0.882 in the training, internal and external validation cohorts, respectively. Similarly, MLP showed good accuracy in distinguish occult LA-ESCC in subgroup of cT<sub>1–2</sub>N<sub>0</sub>M<sub>0</sub> diagnosed by clinicians with 0.803 and 0.789 in two validation cohorts respectively. By incorporating the radiomics signature with clinical signature, a predictive nomogram demonstrated superior prediction performance with an AUC of 0.877 and accuracy of 0.85 in external validation cohort.</p></div><div><h3>Conclusion</h3><p>The radiomics and machine learning model can offers improved accuracy in prediction of occult LA-ESCC, providing valuable assistance to clinicians when choosing treatment plans.</p></div>","PeriodicalId":48975,"journal":{"name":"Translational Oncology","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1936523324001773/pdfft?md5=0207720e49b74e9b9f1e7ceaddcf0928&pid=1-s2.0-S1936523324001773-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1936523324001773","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Development and validation of a radiomics model for predicting occult locally advanced esophageal squamous cell carcinoma (LA-ESCC) on computed tomography (CT) radiomic features before implementation of treatment.

Methods

The study retrospectively collected 574 patients with esophageal squamous cell carcinoma (ESCC) from two medical centers, which were divided into three cohorts for training, internal and external validation. After delineating volume of interest (VOI), radiomics features were extracted and subjected to feature selection using three robust methods. Subsequently, 10 machine learning models were constructed, among which the optimal model was utilized to establish a radiomics signature. Furthermore, a predictive nomogram incorporating both clinical and radiomics signatures was developed. The performance of these models was evaluated through receiver operating characteristic curves, calibration curves, decision curve analysis as well as measures including accuracy, sensitivity, and specificity.

Results

A total of 19 radiomics features were selected. The multilayer perceptron (MLP), which was found to be optimal, achieved an AUC of 0.919, 0.864 and 0.882 in the training, internal and external validation cohorts, respectively. Similarly, MLP showed good accuracy in distinguish occult LA-ESCC in subgroup of cT1–2N0M0 diagnosed by clinicians with 0.803 and 0.789 in two validation cohorts respectively. By incorporating the radiomics signature with clinical signature, a predictive nomogram demonstrated superior prediction performance with an AUC of 0.877 and accuracy of 0.85 in external validation cohort.

Conclusion

The radiomics and machine learning model can offers improved accuracy in prediction of occult LA-ESCC, providing valuable assistance to clinicians when choosing treatment plans.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于CT放射组学和机器学习的预测模型在治疗前诊断隐匿性局部晚期食管鳞状细胞癌中的应用:一项双中心研究。
目的:开发并验证放射组学模型,用于在实施治疗前根据计算机断层扫描(CT)放射组学特征预测隐匿性局部晚期食管鳞状细胞癌(LA-ESCC):研究回顾性收集了两个医疗中心的574名食管鳞状细胞癌(ESCC)患者,将其分为三个队列进行训练、内部和外部验证。划定感兴趣体积(VOI)后,提取放射组学特征,并使用三种稳健方法进行特征选择。随后,构建了 10 个机器学习模型,并利用其中的最优模型建立了放射组学特征。此外,还开发了一个包含临床和放射组学特征的预测提名图。通过接收者操作特征曲线、校准曲线、决策曲线分析以及准确性、灵敏度和特异性等指标,对这些模型的性能进行了评估:结果:共选取了 19 个放射组学特征。多层感知器(MLP)被认为是最佳的,其在训练、内部和外部验证队列中的AUC分别达到了0.919、0.864和0.882。同样,在临床医生诊断的 cT1-2N0M0 亚组中,MLP 在区分隐匿性 LA-ESCC 方面也表现出了良好的准确性,在两个验证组中分别达到了 0.803 和 0.789。通过将放射组学特征与临床特征相结合,预测提名图显示出更优越的预测性能,在外部验证队列中的AUC为0.877,准确率为0.85:放射组学和机器学习模型可提高隐匿性 LA-ESCC 预测的准确性,为临床医生选择治疗方案提供有价值的帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.40
自引率
2.00%
发文量
314
审稿时长
54 days
期刊介绍: Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
期刊最新文献
Transient-resting culture after activation enhances the generation of CD8+ stem cell-like memory T cells from peripheral blood mononuclear cells Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma FERMT1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by activating EGFR/AKT/β-catenin and EGFR/ERK pathways GDF15 and LCN2 for early detection and prognosis of pancreatic cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1